NCT05913141View on ClinicalTrials.gov

PDO/PDO-TIL/PDOTS for Drug Screen

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Liver CancerMetastatic Liver Cancer
Interventions
OTHER

Drug screen with PDO/PDO-TIL/PDOTS

Drug screen with patient-derived organoids, patient-derived organoids-tumor-infiltrating lymphocyte coculture system, or patient-derived organotypic tissue spheroids.

Trial Locations (1)

200032

RECRUITING

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER